NO980439L - Detektering av genetisk predisposisjon for periodontal sykdom - Google Patents

Detektering av genetisk predisposisjon for periodontal sykdom

Info

Publication number
NO980439L
NO980439L NO980439A NO980439A NO980439L NO 980439 L NO980439 L NO 980439L NO 980439 A NO980439 A NO 980439A NO 980439 A NO980439 A NO 980439A NO 980439 L NO980439 L NO 980439L
Authority
NO
Norway
Prior art keywords
periodontal disease
detection
genetic predisposition
patient
genetic polymorphism
Prior art date
Application number
NO980439A
Other languages
English (en)
Norwegian (no)
Other versions
NO980439D0 (no
Inventor
Kenneth S Kornmann
Gordon W Duff
Original Assignee
Kenneth S Kornmann
Gordon W Duff
Medical Science Sys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth S Kornmann, Gordon W Duff, Medical Science Sys Inc filed Critical Kenneth S Kornmann
Publication of NO980439D0 publication Critical patent/NO980439D0/no
Publication of NO980439L publication Critical patent/NO980439L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO980439A 1995-08-03 1998-02-02 Detektering av genetisk predisposisjon for periodontal sykdom NO980439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/510,696 US5686246A (en) 1995-08-03 1995-08-03 Detecting genetic predisposition to periodontal disease
PCT/US1996/012455 WO1997006180A1 (en) 1995-08-03 1996-08-02 Detecting genetic predisposition to periodontal disease

Publications (2)

Publication Number Publication Date
NO980439D0 NO980439D0 (no) 1998-02-02
NO980439L true NO980439L (no) 1998-03-13

Family

ID=24031795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980439A NO980439L (no) 1995-08-03 1998-02-02 Detektering av genetisk predisposisjon for periodontal sykdom

Country Status (25)

Country Link
US (1) US5686246A (is)
EP (2) EP0853630A4 (is)
JP (1) JP4042811B2 (is)
KR (1) KR19990036067A (is)
CN (1) CN1198166A (is)
AR (1) AR003182A1 (is)
AT (1) ATE207927T1 (is)
AU (1) AU719965B2 (is)
BR (1) BR9604044A (is)
CA (1) CA2228424C (is)
DE (1) DE69616478T2 (is)
DK (1) DK0769560T3 (is)
ES (1) ES2166866T3 (is)
ID (1) ID17246A (is)
IL (1) IL123053A (is)
IS (1) IS4653A (is)
MX (1) MX9800941A (is)
MY (1) MY132156A (is)
NO (1) NO980439L (is)
NZ (1) NZ315836A (is)
PT (1) PT769560E (is)
SI (1) SI9620098A (is)
TW (1) TW406130B (is)
WO (1) WO1997006180A1 (is)
ZA (1) ZA966585B (is)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951721B2 (en) * 1996-02-12 2005-10-04 Gene Logic Inc. Method for determining the haplotype of a human BRCA1 gene
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US7820383B2 (en) * 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction
GB9723553D0 (en) * 1997-11-07 1998-01-07 Duff Gordon W Prediction of the risk of chronic obstructive airway disease
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
WO1999011822A1 (en) * 1997-09-03 1999-03-11 Gene Logic Inc. Method for predicting prognosis and treatment response for genetically based abnormalities
ES2297900T3 (es) * 1997-11-07 2008-05-01 Interleukin Genetics, Inc. Diagnosis y terapia para la enfermedad obstructiva cronica de las vias respiratorias.
US6746839B1 (en) 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
US6130042A (en) * 1998-03-05 2000-10-10 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for diagnosing periodontal disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
IL139131A0 (en) * 1998-04-21 2001-11-25 Interleukin Genetics Inc Fetal testing for prediction of low birth weight
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US6225069B1 (en) * 2000-02-29 2001-05-01 The Board Of Trustees Of The University Of Arkansas Methods to identify genetic predisposition to alzheimer's disease
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
DE10112348A1 (de) * 2001-03-13 2002-10-02 Antje Roetger Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen
JP2005500032A (ja) * 2001-06-15 2005-01-06 インターリューキン ジェネティックス インコーポレイテッド 老化関連症状の早期発現を検出および治療する方法
AU2002359431A1 (en) * 2001-11-19 2003-06-10 Interleukin Genetics, Inc. Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
US20080311581A1 (en) * 2001-11-19 2008-12-18 David Wyllie Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US20030148288A1 (en) * 2002-02-01 2003-08-07 Yi-Wei Tang Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
US20040229228A1 (en) * 2002-07-25 2004-11-18 Northwestern University Il-1 genotype in early kidney allograft rejection
AU2003287955B2 (en) 2002-09-30 2007-06-21 Novartis Ag Methods to predict cholesterol elevations during immunosuppressant therapy
JP2007501627A (ja) * 2003-08-08 2007-02-01 インタールーキン ジェネティックス インク 骨粗鬆症のための診断法および治療法
US20070003947A1 (en) * 2005-01-18 2007-01-04 Decarlo Arthur A Detecting genetic risk for periodontal disease
EP2361933A3 (en) 2005-01-26 2012-05-02 Amgen Fremont Inc. Antibodies against interleukin-1 beta
WO2007050794A2 (en) * 2005-10-25 2007-05-03 Interleuken Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
US8101360B2 (en) * 2006-11-15 2012-01-24 Interleukin Genetics, Inc. IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
US7925192B2 (en) * 2007-09-04 2011-04-12 Ricoh Company, Ltd. Developing roller, developing device, process cartridge, and image forming apparatus
CA2705142A1 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
US20100098775A1 (en) * 2008-05-02 2010-04-22 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
EP2304052A2 (en) * 2008-05-02 2011-04-06 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
AU2011338210B2 (en) 2010-12-09 2016-05-12 Orig3N, Inc. Improved method and kit for determining severity and progression of periodontal disease
EP3402900A1 (en) 2016-01-12 2018-11-21 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
KR101894018B1 (ko) * 2017-02-09 2018-08-31 주식회사 테라젠이텍스 치주 질환의 위험도를 예측하기 위한 조성물, 마이크로어레이, 및 키트, 및 이를 이용한 방법
WO2020245402A1 (en) 2019-06-06 2020-12-10 Cardioforecast Ltd Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582788A (en) * 1982-01-22 1986-04-15 Cetus Corporation HLA typing method and cDNA probes used therein
US5110920A (en) * 1982-01-22 1992-05-05 Cetus Corporation HLA typing method and DNA probes used therein
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5268267A (en) * 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
US5158871A (en) * 1988-02-12 1992-10-27 University Of Connecticut Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5328829A (en) * 1990-07-05 1994-07-12 Forsyth Dental Infirmary For Children Method of determining sites of active periodontal disease

Also Published As

Publication number Publication date
IL123053A0 (en) 1998-12-06
SI9620098A (sl) 1998-10-31
AU6763396A (en) 1997-03-05
ES2166866T3 (es) 2002-05-01
MX9800941A (es) 1998-10-31
AU719965B2 (en) 2000-05-18
CN1198166A (zh) 1998-11-04
EP0769560A2 (en) 1997-04-23
NO980439D0 (no) 1998-02-02
CA2228424A1 (en) 1997-02-20
ZA966585B (en) 1997-02-26
IS4653A (is) 1998-01-19
PT769560E (pt) 2002-04-29
DE69616478D1 (de) 2001-12-06
EP0769560B1 (en) 2001-10-31
ID17246A (id) 1997-12-11
JP4042811B2 (ja) 2008-02-06
DK0769560T3 (da) 2002-02-18
NZ315836A (en) 1999-10-28
ATE207927T1 (de) 2001-11-15
JP2001517067A (ja) 2001-10-02
TW406130B (en) 2000-09-21
EP0853630A1 (en) 1998-07-22
WO1997006180A1 (en) 1997-02-20
MY132156A (en) 2007-09-28
US5686246A (en) 1997-11-11
AR003182A1 (es) 1998-07-08
KR19990036067A (ko) 1999-05-25
EP0853630A4 (en) 1999-10-27
EP0769560A3 (en) 1999-11-24
DE69616478T2 (de) 2002-08-08
CA2228424C (en) 2005-12-27
BR9604044A (pt) 1998-06-09
IL123053A (en) 2000-01-31

Similar Documents

Publication Publication Date Title
NO980439L (no) Detektering av genetisk predisposisjon for periodontal sykdom
WO2000037679A3 (en) Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis
CA2282746A1 (en) Prediction of coronary artery disease
FR2755149B1 (fr) Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
DE59609222D1 (de) Amperometrischer Biosensor
DE69422687D1 (de) Biosensor zur hämatokritbestimmung
EP0915173A3 (en) Kit and method for fluorescence based detection assay
GB2375539A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
LU91756I2 (fr) Denosumab
DE69719057D1 (de) Verfahren zur signalverstärkung
DK0950113T3 (da) Detektion af genetisk prædisposition for synstruende diabetisk retinopati
FR2708350B1 (fr) Méthode d'analyse de signaux sismiques.
ES2166822T3 (es) Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf.
DK0648335T3 (da) Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
IL123834A0 (en) Diagnostic method and kit for determining rh blood group genotype
EP0398709A3 (en) Genetic diagnosis of torsion dystonia
DK0514490T3 (da) Allelisk forbindelse af human dopamin (D2) receptorgenet i kompulsionsforstyrrelser, såsom alkoholisme
ATE294237T1 (de) S?ugetier thymokingene
DE69618904D1 (de) Probenanalyse
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
WO2002090585A3 (en) Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
FR2668162B1 (fr) Fragments d'adn, procede et coffret de diagnostic pour la detection des porteurs de la mutation delta-f-508 responsable de la mucoviscidose.
NO932160L (no) Fremgangsmaate for deteksjon av cathepsin G og alfa-1-antichymotrypsin komplekser
DE69635025D1 (de) Neues verfahren zum nachweis von cryptosporidium

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application